Utama › Penyakit Saraf Degeneratif › Massachusetts
Kajian klinikal Penyakit Saraf Degeneratif di Massachusetts
6 kajian untuk Penyakit Saraf Degeneratif sedang mencari peserta di lokasi di Massachusetts.
Bandar di Massachusetts
Teks kajian rasmi (Bahasa Inggeris)
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
- Massachusetts General Hospital /ID# 270960, Boston
Mengambil pesertaFasa 1/2
6 Months · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05757141A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Massachusetts General Hospital - Charlestown, Charlestown
- K2 Medical Research - Foxborough, Foxborough
- Neurology Center of New England, Foxborough
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 55 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07589595A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
Mengambil pesertaFasa 1
Umur 50 hingga 85 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06297590PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Boston University, Boston
- Massachusetts General Hospital, Boston
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 30 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT04477785Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
- Boston Children's Hospital, Boston
Mengambil pesertaKajian pemerhatian
1 Month – 30 Years · Semua jantina · Dikemas kini 18 Mac 2026 · NCT05354622Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- McLean Hospital, Belmont
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 89 · Semua jantina · Dikemas kini 6 Nov 2025 · NCT05245903Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.